Literature DB >> 21439260

The search for biomarkers and endophenotypes in functional gastrointestinal disorders.

Emeran A Mayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21439260      PMCID： PMC3839575          DOI： 10.1053/j.gastro.2011.03.023

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  16 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

Review 2.  Idiopathic pain disorders--pathways of vulnerability.

Authors:  Luda Diatchenko; Andrea G Nackley; Gary D Slade; Roger B Fillingim; William Maixner
Journal:  Pain       Date:  2006-06-13       Impact factor: 6.961

Review 3.  The value, qualification, and regulatory use of surrogate end points in drug development.

Authors:  C D Lathia; D Amakye; W Dai; C Girman; S Madani; J Mayne; P MacCarthy; P Pertel; L Seman; A Stoch; P Tarantino; C Webster; S Williams; J A Wagner
Journal:  Clin Pharmacol Ther       Date:  2009-05-27       Impact factor: 6.875

4.  Biomarkers: principles, policies, and practice.

Authors:  J A Wagner
Journal:  Clin Pharmacol Ther       Date:  2009-07       Impact factor: 6.875

Review 5.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

Review 6.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

Review 7.  Tests of gastric neuromuscular function.

Authors:  Henry P Parkman; Michael P Jones
Journal:  Gastroenterology       Date:  2009-03-16       Impact factor: 22.682

8.  Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation?

Authors:  L Van Oudenhove; J Vandenberghe; B Geeraerts; R Vos; P Persoons; B Fischler; K Demyttenaere; J Tack
Journal:  Gut       Date:  2008-07-14       Impact factor: 23.059

Review 9.  Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence.

Authors:  F W Sabb; A C Burggren; R G Higier; J Fox; J He; D S Parker; R A Poldrack; W Chu; T D Cannon; N B Freimer; R M Bilder
Journal:  Neuroscience       Date:  2009-05-18       Impact factor: 3.590

Review 10.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.